Genetic contributions to epigenetic-defined endotypes of allergic phenotypes in children
- PMID: 40614707
- PMCID: PMC12256822
- DOI: 10.1016/j.ajhg.2025.05.006
Genetic contributions to epigenetic-defined endotypes of allergic phenotypes in children
Abstract
Asthma is a common respiratory disease, with contributions from both genes and the environment and significant heterogeneity in underlying endotypes; yet, little is known about the relative contributions of each to these endotypes. To address this gap, we used nasal mucosal cell DNA methylation (DNAm) and gene expression and genotypes for 284 children in the Urban Environment and Childhood Asthma (URECA) birth cohort. Using an unbiased data-reduction approach and 37,256 CpGs on a custom-content Asthma&Allergy array, empirical Bayesian factorization was implemented to identify three DNAm signatures that were associated with phenotypes reflecting allergic diseases (allergic asthma and allergic rhinitis), allergic sensitization (atopy) (specific and total immunoglobulin E), and/or type 2 inflammation (eosinophil count and fractional exhaled nitric oxide [FeNO]). These associations were replicated in the Infant Susceptibility to Pulmonary Infections and Asthma (INSPIRE) and the Children's Respiratory Environment Workgroup (CREW) cohorts. The genes that were correlated with each signature in URECA reflected three cardinal endotypes of asthma: inhibited immune response to microbes, impaired epithelial barrier integrity, and activated type 2 immune pathways. To estimate the genetic contributions to these signatures, we used a common set of genotypes available in the three cohorts. The joint SNP heritability of each signature was 0.21 (p = 0.037), 0.26 (p = 1.7 × 10-8), and 0.17 (p = 7.7 × 10-6), respectively. The heritabilities of the DNAm signatures suggest that genetic variation contributes significantly to epigenetic signatures of allergic phenotypes and that susceptibility to the development of specific endotypes of asthma is present at birth and is poised to mediate individual epigenetic responses to early-life environments.
Keywords: DNA methylation; T2 inflammation; asthma and allergy endotypes; barrier function; viral response.
Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests L.B.B. is a member of the GINA Science Committee and reports personal fees from GlaxoSmithKline, Genentech/Novartis, Merck, Teva, Boehringer Ingelheim, AstraZeneca, Avillion, WebMD/Medscape, Sanofi/Regeneron, Vectura, Circassia, OM Pharma, and Kinaset, for DSMB from AstraZeneca, DBV Technologies, and Vertex; and royalties from Elsevier outside the submitted work. R.A.W. receives research support from Aimmune, ALK, DBV, Genentech, Novartis, Siolta, and FARE, and consulting fees from Genentech. C.M.S. reports personal fees from Chiesi and Enzyvant, and royalties from UpToDate outside the submitted work. T.H. reports grants from the World Health Organization during the conduct of the study and personal fees from the American Thoracic Society, Parker B. Francis Council of Scientific Advisors, American Academy of Allergy, Asthma and Immunology (AAAI), UpToDate, Pfizer, and Sanofi-Pasteur outside the submitted work. D.J.J. has received funding from GlaxoSmithKline and Regeneron, personal fees for Data and Safety Monitoring Board from Pfizer and AstraZeneca; and personal fees for consulting from AstraZeneca, Avillion, GlaxoSmithKline, Sanofi, and Regeneron. J.E.G. reports personal fees from Arrowhead Pharmaceuticals, AstraZeneca, and Meissa Vaccines Inc., and stock options for Meissa Vaccines Inc. outside the submitted work. C.G.M. reports personal fees from SignatureDx outside the submitted work.
Figures




Update of
-
Genetic contributions to epigenetic-defined endotypes of allergic phenotypes in children.medRxiv [Preprint]. 2024 Oct 4:2024.10.03.24314618. doi: 10.1101/2024.10.03.24314618. medRxiv. 2024. Update in: Am J Hum Genet. 2025 Jul 3;112(7):1610-1624. doi: 10.1016/j.ajhg.2025.05.006. PMID: 40034775 Free PMC article. Updated. Preprint.
References
-
- Lotvall J., Akdis C.A., Bacharier L.B., Bjermer L., Casale T.B., Custovic A., Lemanske R.F., Jr., Wardlaw A.J., Wenzel S.E., Greenberger P.A. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J. Allergy Clin. Immunol. 2011;127:355–360. - PubMed
-
- Pinart M., Benet M., Annesi-Maesano I., von Berg A., Berdel D., Carlsen K.C.L., Carlsen K.H., Bindslev-Jensen C., Eller E., Fantini M.P., et al. Comorbidity of eczema, rhinitis, and asthma in IgE-sensitised and non-IgE-sensitised children in MeDALL: a population-based cohort study. Lancet Respir. Med. 2014;2:131–140. - PubMed
MeSH terms
Grants and funding
- P01 ES009600/ES/NIEHS NIH HHS/United States
- N01 AI025496/AI/NIAID NIH HHS/United States
- R21 AI059415/AI/NIAID NIH HHS/United States
- R56 AI050681/AI/NIAID NIH HHS/United States
- R01 ES008977/ES/NIEHS NIH HHS/United States
- U10 HL064305/HL/NHLBI NIH HHS/United States
- R01 ES013163/ES/NIEHS NIH HHS/United States
- U19 AI104317/AI/NIAID NIH HHS/United States
- HHSN272200900052C/AI/NIAID NIH HHS/United States
- R01 HD061879/HD/NICHD NIH HHS/United States
- R56 HG002585/HG/NHGRI NIH HHS/United States
- R01 AI061774/AI/NIAID NIH HHS/United States
- UL1 TR001079/TR/NCATS NIH HHS/United States
- R01 AI035786/AI/NIAID NIH HHS/United States
- R01 AI110450/AI/NIAID NIH HHS/United States
- R21 ES022321/ES/NIEHS NIH HHS/United States
- R01 HL113010/HL/NHLBI NIH HHS/United States
- R01 ES019890/ES/NIEHS NIH HHS/United States
- M01 RR000533/RR/NCRR NIH HHS/United States
- N01 AI025482/AI/NIAID NIH HHS/United States
- R21 AI069271/AI/NIAID NIH HHS/United States
- UL1 RR024156/RR/NCRR NIH HHS/United States
- UM2 AI117870/AI/NIAID NIH HHS/United States
- UL1 RR025771/RR/NCRR NIH HHS/United States
- UH3 OD023282/OD/NIH HHS/United States
- K01 AI070606/AI/NIAID NIH HHS/United States
- R37 AI060040/AI/NIAID NIH HHS/United States
- UL1 RR024992/RR/NCRR NIH HHS/United States
- U19 AI095230/AI/NIAID NIH HHS/United States
- M01 RR000071/RR/NCRR NIH HHS/United States
- UM1 AI114271/AI/NIAID NIH HHS/United States
- R01 HG002585/HG/NHGRI NIH HHS/United States
- R01 AG080590/AG/NIA NIH HHS/United States
- R21 AI080066/AI/NIAID NIH HHS/United States
- M01 RR000052/RR/NCRR NIH HHS/United States
- UG3 OD035518/OD/NIH HHS/United States
- R01 MH061879/MH/NIMH NIH HHS/United States
- UG3 OD023282/OD/NIH HHS/United States
- R01 ES011170/ES/NIEHS NIH HHS/United States
- P01 AI089473/AI/NIAID NIH HHS/United States
- R01 AI050681/AI/NIAID NIH HHS/United States
- UL1 TR000040/TR/NCATS NIH HHS/United States
- P01 HL070831/HL/NHLBI NIH HHS/United States
- UL1 TR002243/TR/NCATS NIH HHS/United States
- R01 AI060040/AI/NIAID NIH HHS/United States
- U19 AI095227/AI/NIAID NIH HHS/United States
- HHSN272201000052I/AI/NIAID NIH HHS/United States
- UL1 TR002345/TR/NCATS NIH HHS/United States
- R01 AI051598/AI/NIAID NIH HHS/United States
- P30 ES009089/ES/NIEHS NIH HHS/United States
- R01 HD082147/HD/NICHD NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous